A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
about
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of Pertuzumab in Addit ...... Positive Primary Breast Cancer
@en
type
label
A Study of Pertuzumab in Addit ...... Positive Primary Breast Cancer
@en
prefLabel
A Study of Pertuzumab in Addit ...... Positive Primary Breast Cancer
@en
P17
P4844
P6153
P1132
P131
P1476
A Randomized Multicenter, Doub ...... Positive Primary Breast Cancer
@en
P17
P1813
APHINITY
@en
P3098
NCT01358877
P4844
P580
2011-11-08T00:00:00Z
P582
2016-12-19T00:00:00Z